← Back to catalogue

AmplideX Fragile X Dx & Carrier Screen Kit

FDA UDI

Class II (US FDA UDI)

by Asuragen, Inc.

Identity

Trade Name
AmplideX Fragile X Dx & Carrier Screen Kit FDA UDI
Generic Name
Fragile X syndrome IVD, kit, nucleic acid technique (NAT) FDA UDI
Model / Reference
49591 FDA UDI

Identifiers

Catalog Number
49591 FDA UDI
Primary DI / UDI-DI
00863840000254 FDA UDI
510(k) Number
FDA Product Code
OYV FDA UDI
GMDN Term
Fragile X syndrome IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.5970 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Fragile X syndrome IVD, kit, nucleic acid technique (NAT)

AmplideX Fragile X Dx & Carrier Screen Kit by Asuragen, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Asuragen, Inc.

Sources (1)

  • FDA UDI 04a6fb18-5ac0-4b00-bdd8-770addffa1dd 35 fields · synced May 30, 2026